UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (164) 164
humans (163) 163
life sciences & biomedicine (163) 163
female (133) 133
male (124) 124
middle aged (97) 97
aged (85) 85
adult (70) 70
biological and medical sciences (55) 55
medical sciences (54) 54
italy - epidemiology (39) 39
oncology (36) 36
treatment outcome (33) 33
hematology (32) 32
risk factors (32) 32
aged, 80 and over (31) 31
italy (28) 28
prognosis (23) 23
retrospective studies (23) 23
care and treatment (22) 22
adolescent (21) 21
follow-up studies (21) 21
public, environmental & occupational health (20) 20
abridged index medicus (19) 19
general & internal medicine (19) 19
research (19) 19
analysis (18) 18
disease-free survival (18) 18
cancer (17) 17
multiple myeloma - drug therapy (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
child (15) 15
cohort studies (15) 15
medicine, general & internal (15) 15
prospective studies (15) 15
time factors (15) 15
multiple myeloma - mortality (14) 14
survival analysis (14) 14
gastroenterology & hepatology (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
endocrinology & metabolism (12) 12
epidemiology (12) 12
health care sciences & services (12) 12
incidence (12) 12
odds ratio (12) 12
antineoplastic combined chemotherapy protocols - administration & dosage (11) 11
health aspects (11) 11
kaplan-meier estimate (11) 11
prednisone - administration & dosage (11) 11
proportional hazards models (11) 11
transplantation (11) 11
tumors (11) 11
hematologic and hematopoietic diseases (10) 10
immunodeficiencies. immunoglobulinopathies (10) 10
immunoglobulinopathies (10) 10
immunopathology (10) 10
internal medicine (10) 10
logistic models (10) 10
melphalan - administration & dosage (10) 10
oncology, experimental (10) 10
prevalence (10) 10
surgery (10) 10
survival rate (10) 10
thalidomide - administration & dosage (10) 10
transplantation, autologous (10) 10
chemotherapy (9) 9
clinical neurology (9) 9
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (9) 9
medicine & public health (9) 9
neurology (9) 9
neurosciences & neurology (9) 9
prednisone - adverse effects (9) 9
risk assessment (9) 9
stem cells (9) 9
surveys and questionnaires (9) 9
age factors (8) 8
cardiovascular system & cardiology (8) 8
clinical trials (8) 8
cyclophosphamide - adverse effects (8) 8
drug therapy (8) 8
hematology, oncology and palliative medicine (8) 8
hospitals (8) 8
mortality (8) 8
neoplasm staging (8) 8
patients (8) 8
practice guidelines as topic (8) 8
recurrence (8) 8
respiratory system (8) 8
urology & nephrology (8) 8
young adult (8) 8
colorectal cancer (7) 7
combined modality therapy (7) 7
comorbidity (7) 7
cyclophosphamide - administration & dosage (7) 7
diabetes (7) 7
general aspects (7) 7
multiple myeloma (7) 7
multiple myeloma - therapy (7) 7
multivariate analysis (7) 7
nephrology. urinary tract diseases (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 10, pp. 895 - 905
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Immunopathology | General aspects | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Transplantation, Autologous | Consolidation Chemotherapy | Antineoplastic Agents, Alkylating - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Melphalan - adverse effects | Adult | Maintenance Chemotherapy | Neutropenia - chemically induced | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Aged | Antineoplastic Agents, Alkylating - adverse effects | Stem Cell Transplantation - adverse effects | Complications and side effects | Care and treatment | Patient outcomes | Multiple myeloma | Stem cells | Transplantation | Research | Health aspects | Autografts | Chemotherapy | Cell survival | Transplants & implants | Melphalan | Stem cell transplantation | Death | Prednisone | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Recenti progressi in medicina, ISSN 0034-1193, 09/2014, Volume 105, Issue 9, pp. 315 - 316
Journal Article
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
Journal Article